Published in J Cancer Res Clin Oncol on July 10, 2003
Proposals for the classification of the myelodysplastic syndromes. Br J Haematol (1982) 10.90
Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med (1991) 2.40
The problem of clonality in aplastic anemia: Dr Dameshek's riddle, restated. Blood (1992) 1.99
Hypocellular myelodysplastic syndromes (MDS): new proposals. Br J Haematol (1995) 1.80
Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasia. Br J Haematol (1989) 1.56
Successful treatment of refractory anemia with high-dose methylprednisolone. Am J Hematol (1990) 1.41
Successful immunosuppressive treatment after failure of erythropoietin therapy in two subjects with refractory anaemia. Br J Haematol (1993) 1.38
Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haematol (1995) 1.31
Immunological abnormalities in myelodysplastic syndromes. I. Serum immunoglobulins and autoantibodies. Br J Haematol (1986) 1.19
Antithymocyte globulin for patients with myelodysplastic syndrome. Br J Haematol (1997) 1.17
World Health Organization classification of the acute leukemias and myelodysplastic syndrome. Int J Hematol (2000) 1.12
Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med (1983) 1.06
Clonal cytogenetic abnormalities in patients with otherwise typical aplastic anemia. Exp Hematol (1987) 1.03
A critical appraisal of low-dose cytosine arabinoside in patients with acute non-lymphocytic leukemia and myelodysplastic syndromes. J Clin Oncol (1986) 1.02
Immunological abnormalities in myelodysplastic syndromes. Semin Hematol (1996) 1.02
Identification of a specific HLA class II haplotype strongly associated with susceptibility to cyclosporine-dependent aplastic anemia. Blood (1994) 1.01
Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. Br J Haematol (1998) 0.96
Response to immunosuppressive therapy and an HLA-DRB1 allele in patients with aplastic anaemia: HLA-DRB1*1501 does not predict response to antithymocyte globulin. Br J Haematol (1996) 0.88
Abnormal cytogenetic clones in patients with aplastic anaemia: response to immunosuppressive therapy. Br J Haematol (1999) 0.88
A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. Blood (1988) 0.86
Immunosuppressive therapy for hypoplastic myelodysplastic syndrome. Cancer (1997) 0.84
Antilymphocyte globulin for myelodysplastic syndrome. Br J Haematol (1988) 0.82
Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood (1990) 0.78
Good response to cyclosporine therapy in patients with myelodysplastic syndromes having the HLA-DRB1*1501 allele. Leukemia (2000) 0.76
Autoimmune myelodysplasias. Semin Hematol (1991) 0.75
Intractable pruritus in non-Hodgkin lymphoma/CLL: rapid response to IFN alpha. Br J Haematol (1996) 0.75
Multiple responses of aplastic anemia to low-dose cyclosporine therapy despite development of a myelodysplastic syndrome. Am J Hematol (1989) 0.75
A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia. Exp Hematol (1994) 0.75
Complete remission of refractory anemia following a single high dose of cyclophosphamide. Ann Hematol (1999) 0.75
Differentiation therapy of myelodysplastic syndromes with retinoic acid. Leuk Lymphoma (1994) 0.75
Trilineage recovery by combination therapy with recombinant human granulocyte colony-stimulating factor and erythropoietin in patients with aplastic anemia and refractory anemia. Stem Cells (1994) 0.75
Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun (2006) 3.35
Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (2003) 3.18
Effects of oral branched-chain amino acid granules on event-free survival in patients with liver cirrhosis. Clin Gastroenterol Hepatol (2005) 2.44
Prognostic value of energy metabolism in patients with viral liver cirrhosis. Nutrition (2002) 2.05
Polarity-dependent distribution of angiomotin localizes Hippo signaling in preimplantation embryos. Curr Biol (2013) 1.86
Leflunomide protects from T-cell-mediated liver injury in mice through inhibition of nuclear factor kappaB. Hepatology (2004) 1.76
Therapeutic effect of intraarterial prednisolone injection in severe intestinal Behçet's disease. J Gastroenterol (2002) 1.63
Nutritional assessment in liver cirrhosis. J Gastroenterol (2006) 1.58
(-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clin Cancer Res (2005) 1.55
Long-term study of posterior capsular opacification prevention with endocapsular equator rings in humans. Arch Ophthalmol (2011) 1.53
Preventing posterior capsular opacification with an endocapsular equator ring in a young human eye: 2-year follow-up. Arch Ophthalmol (2007) 1.52
Serum soluble CD27 level is associated with outcome in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone. Leuk Lymphoma (2012) 1.45
Coexistence of inversion 16 and the Philadelphia chromosome comprising P190 BCR/ABL in chronic myeloid leukemia blast crisis. Int J Hematol (2011) 1.44
Dietary supplementation with branched-chain amino acids suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ-db/db mice. Cancer Sci (2009) 1.44
Mediastinal lymph node staging in potentially resectable non-small cell lung cancer: a prospective comparison of CT and EUS/EUS-FNA. Respiration (2009) 1.42
Computer-aided diagnosis: the emerging of three CAD systems induced by Japanese health care needs. Comput Methods Programs Biomed (2008) 1.42
Radioimmunotherapy with 90Y-ibritumomab tiuxetan for a hemodialysis patient with relapsed follicular lymphoma. Leuk Lymphoma (2013) 1.39
Diffuse esophageal spasm. Gastrointest Endosc (2004) 1.38
Imaging exosome transfer from breast cancer cells to stroma at metastatic sites in orthotopic nude-mouse models. Adv Drug Deliv Rev (2012) 1.34
Primary gastrointestinal follicular lymphoma involving the duodenal second portion is a distinct entity: a multicenter, retrospective analysis in Japan. Cancer Sci (2011) 1.33
Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol Biomarkers Prev (2008) 1.26
Cancer chemoprevention by carotenoids. Molecules (2012) 1.24
Metallic stents are more efficacious than plastic stents in unresectable malignant hilar biliary strictures: a randomized controlled trial. J Hepatobiliary Pancreat Sci (2013) 1.23
Comparing and combining algorithms for computer-aided detection of pulmonary nodules in computed tomography scans: The ANODE09 study. Med Image Anal (2010) 1.19
The RING finger protein, RNF8, interacts with retinoid X receptor alpha and enhances its transcription-stimulating activity. J Biol Chem (2004) 1.18
Analysis of gene expression profile induced by hepatocyte nuclear factor 4alpha in hepatoma cells using an oligonucleotide microarray. J Biol Chem (2002) 1.18
Retinoids in cancer chemoprevention. Curr Cancer Drug Targets (2004) 1.16
Imageable fluorescent metastasis resulting in transgenic GFP mice orthotopically implanted with human-patient primary pancreatic cancer specimens. Anticancer Res (2012) 1.15
Use of samples from endoscopic ultrasound-guided 19-gauge fine-needle aspiration in diagnosis of autoimmune pancreatitis. Clin Gastroenterol Hepatol (2011) 1.15
Endoscopic ultrasound-guided fine needle aspiration biopsy for diagnosis of lymphoproliferative disorders: feasibility of immunohistological, flow cytometric, and cytogenetic assessments. Am J Gastroenterol (2011) 1.14
Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan. Hepatol Res (2010) 1.13
Lack of tumor necrosis factor receptor type 1 inhibits liver fibrosis induced by carbon tetrachloride in mice. Cytokine (2005) 1.12
Disruption of protein kinase Ceta results in impairment of wound healing and enhancement of tumor formation in mouse skin carcinogenesis. Cancer Res (2003) 1.12
Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection--a randomized controlled study. J Gastroenterol (2009) 1.12
Lack of tumor necrosis factor alpha induces impaired proliferation of hepatitis B virus-specific cytotoxic T lymphocytes. J Virol (2003) 1.11
Quantitative evaluation of liver function with use of gadoxetate disodium-enhanced MR imaging. Radiology (2011) 1.11
Role of Valpha 14 NKT cells in the development of impaired liver regeneration in vivo. Hepatology (2003) 1.10
Multi-color palette of fluorescent proteins for imaging the tumor microenvironment of orthotopic tumorgraft mouse models of clinical pancreatic cancer specimens. J Cell Biochem (2012) 1.09
Automatic segmentation and recognition of anatomical lung structures from high-resolution chest CT images. Comput Med Imaging Graph (2006) 1.09
Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol (2005) 1.08
EGCG inhibits activation of the insulin-like growth factor-1 receptor in human colon cancer cells. Biochem Biophys Res Commun (2005) 1.08
Guideline on the use of new anticancer drugs for the treatment of Hepatocellular Carcinoma 2010 update. Hepatol Res (2012) 1.07
Role of Valpha14+ NKT cells in the development of Hepatitis B virus-specific CTL: activation of Valpha14+ NKT cells promotes the breakage of CTL tolerance. Int Immunol (2008) 1.06
Needle tract implantation on the esophageal wall after EUS-guided FNA of metastatic mediastinal lymphadenopathy. Gastrointest Endosc (2008) 1.06
BCAA-enriched snack improves nutritional state of cirrhosis. Nutrition (2007) 1.05
EGCG inhibits activation of the insulin-like growth factor (IGF)/IGF-1 receptor axis in human hepatocellular carcinoma cells. Cancer Lett (2007) 1.04
Prevention of second primary tumors by an acyclic retinoid in patients with hepatocellular carcinoma. Updated analysis of the long-term follow-up data. Intervirology (2005) 1.04
(-)-Epigallocatechin gallate causes internalization of the epidermal growth factor receptor in human colon cancer cells. Carcinogenesis (2008) 1.04
EUS-guided pancreatic pseudocyst drainage. Dig Endosc (2009) 1.03
Critical role of CD44 in hepatotoxin-mediated liver injury. J Hepatol (2008) 1.02
Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid. Carcinogenesis (2003) 1.02
Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice. Cancer Sci (2010) 1.02
Impaired liver regeneration in mice by lipopolysaccharide via TNF-alpha/kallikrein-mediated activation of latent TGF-beta. Gastroenterology (2002) 1.01
Long-term survival of a patient with splenic angiosarcoma after resection, high-dose chemotherapy, and autologous peripheral blood stem cell transplantation. Intern Med (2010) 1.01
(-)-Epigallocatechin gallate downregulates EGF receptor via phosphorylation at Ser1046/1047 by p38 MAPK in colon cancer cells. Carcinogenesis (2009) 1.01
Acyclic retinoid inhibits diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BLKS/J- +(db)/+Lepr(db) mice. Cancer Prev Res (Phila) (2010) 1.01
Tumor necrosis factor alpha-induced interleukin-8 production via NF-kappaB and phosphatidylinositol 3-kinase/Akt pathways inhibits cell apoptosis in human hepatocytes. Infect Immun (2002) 1.01
Development of a fully automatic scheme for detection of masses in whole breast ultrasound images. Med Phys (2007) 1.00
Lethal endotoxic shock using alpha-galactosylceramide sensitization as a new experimental model of septic shock. Lab Invest (2006) 1.00
(-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice. Cancer Prev Res (Phila) (2008) 0.99
Transcription factor HNF and hepatocyte differentiation. Hepatol Res (2008) 0.99
Predictive factors for pain relief after endoscopic ultrasound-guided celiac plexus neurolysis. Dig Endosc (2010) 0.98
Non-invasive fluorescent-protein imaging of orthotopic pancreatic-cancer-patient tumorgraft progression in nude mice. Anticancer Res (2012) 0.98
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study. J Gastroenterol (2014) 0.98
EGCG inhibits activation of HER3 and expression of cyclooxygenase-2 in human colon cancer cells. J Exp Ther Oncol (2005) 0.98
Indoleamine 2,3-dioxygenase in tumor tissue indicates prognosis in patients with diffuse large B-cell lymphoma treated with R-CHOP. Ann Hematol (2010) 0.98
Role of EUS in the early detection of small pancreatic cancer. Dig Endosc (2011) 0.97
VEGFR-2-specific ligand VEGF-E induces non-edematous hyper-vascularization in mice. Biochem Biophys Res Commun (2003) 0.97
Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice. Clin Cancer Res (2009) 0.97